Treatment options and considerations for the newly diagnosed myeloma patient.
Rajkumar
Vincent S
VS
Division of Hematology, Mayo Clinic Medical College, Rochester, Minnesota, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003907:Dexamethasone / Q000627:therapeutic use; D017984:Enoxaparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy* / Q000601:surgery; D011379:Prognosis; D013792:Thalidomide / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D017984:Enoxaparin; D013792:Thalidomide; D014859:Warfarin; D003907:Dexamethasone